论文信息 - Selinexor, ARA-C and Idarubicin: An Effective and Tolerable Combination in Patients with Relapsed/Refractory AML: A Multicenter Phase II Study - 字舞流文

Selinexor, ARA-C and Idarubicin: An Effective and Tolerable Combination in Patients with Relapsed/Refractory AML: A Multicenter Phase II Study

M. Heuser | F. Thol | C. Bokemeyer | W. Fiedler | M. Kebenko | C. Brandts | A. Köhler | A. Kranich | A. Trummer | J. Chromik | S. Theile | V. Schlipfenbacher | Chirstoph Schünemann